Literature DB >> 31032899

Translational repression of Ccl5 and Cxcl10 by 4E-BP1 and 4E-BP2 restrains the ability of mouse macrophages to induce migration of activated T cells.

Mirtha William1, Louis-Philippe Leroux1, Visnu Chaparro1, Tyson E Graber2, Tommy Alain2,3, Maritza Jaramillo1.   

Abstract

Signaling through the mechanistic target of rapamycin complex 1 (mTORC1) is a major regulatory node of pro-inflammatory mediator production by macrophages (MΦs). However, it is still unclear whether such regulation relies on selective translational control by two of the main mTORC1 effectors, the eIF4E-binding proteins 1 and 2 (4E-BP1/2). By comparing translational efficiencies of immune-related transcripts of MΦs from WT and 4E-BP1/2 double-KO (DKO) mice, we found that translation of mRNAs encoding the pro-inflammatory chemokines CCL5 and CXCL10 is controlled by 4E-BP1/2. Macrophages deficient in 4E-BP1/2 produced higher levels of CCL5 and CXCL10 upon LPS stimulation, which enhanced chemoattraction of activated T cells. Consistent with this, treatment of WT cells with mTORC1 inhibitors promoted the activation of 4E-BP1/2 and reduced CCL5 and CXCL10 secretion. In contrast, the phosphorylation status of eIF4E did not affect the synthesis of these chemokines since MΦs derived from mice harboring a non-phosphorylatable form of the protein produced similar levels of CCL5 and CXCL10 to WT counterparts. These data provide evidence that the mTORC1-4E-BP1/2 axis contributes to regulate the production of chemoattractants by MΦs by limiting translation efficiency of Ccl5 and Cxcl10 mRNAs, and suggest that 4E-BP1/2 act as immunological safeguards by fine-tuning inflammatory responses in MΦs.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  4E-BP; chemokines; mRNA translation; mTOR; macrophages

Mesh:

Substances:

Year:  2019        PMID: 31032899     DOI: 10.1002/eji.201847857

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

1.  MNK2 governs the macrophage antiinflammatory phenotype.

Authors:  Margarita Bartish; Dongmei Tong; Yangxun Pan; Majken Wallerius; Hui Liu; Johannes Ristau; Sabrina de Souza Ferreira; Tatjana Wallmann; Vincent van Hoef; Laia Masvidal; Thomas Kerzel; Anne-Laure Joly; Christophe Goncalves; Samuel E J Preston; Talin Ebrahimian; Christina Seitz; Jonas Bergh; Kristian Pietras; Stephanie Lehoux; Luigi Naldini; John Andersson; Mario Leonardo Squadrito; Sonia V Del Rincón; Ola Larsson; Charlotte Rolny
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-19       Impact factor: 11.205

2.  Metabolic modulation by CDK4/6 inhibitor promotes chemokine-mediated recruitment of T cells into mammary tumors.

Authors:  Roman V Uzhachenko; Vijaya Bharti; Zhufeng Ouyang; Ashlyn Blevins; Stacey Mont; Nabil Saleh; Hunter A Lawrence; Chengli Shen; Sheau-Chiann Chen; Gregory D Ayers; David G DeNardo; Carlos Arteaga; Ann Richmond; Anna E Vilgelm
Journal:  Cell Rep       Date:  2021-04-06       Impact factor: 9.423

3.  A multi‑omics study of diagnostic markers and the unique inflammatory tumor micro‑environment involved in tuberous sclerosis complex‑related renal angiomyolipoma.

Authors:  Zhan Wang; Xiaoyan Liu; Wenda Wang; Jing Wei; Samuel Seery; Jiyu Xu; Haidan Sun; Yuncui Yu; Yang Zhao; Xu Wang; Zhangcheng Liao; Yanan Li; Wei Sun; Lulu Jia; Yushi Zhang
Journal:  Int J Oncol       Date:  2022-09-16       Impact factor: 5.884

4.  Impact of Interleukin 10 Deficiency on Intestinal Epithelium Responses to Inflammatory Signals.

Authors:  Stamatia Papoutsopoulou; Liam Pollock; Catherine Walker; William Tench; Sakim Shakh Samad; François Bergey; Luca Lenzi; Raheleh Sheibani-Tezerji; Phillip Rosenstiel; Mohammad Tauqeer Alam; Vitor A P Martins Dos Santos; Werner Müller; Barry J Campbell
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

Review 5.  Emerging role of mTOR in tumor immune contexture: Impact on chemokine-related immune cells migration.

Authors:  Jing Jin; Qijie Zhao
Journal:  Theranostics       Date:  2020-05-15       Impact factor: 11.556

6.  Infection by the Protozoan Parasite Toxoplasma gondii Inhibits Host MNK1/2-eIF4E Axis to Promote Its Survival.

Authors:  Louis-Philippe Leroux; Visnu Chaparro; Maritza Jaramillo
Journal:  Front Cell Infect Microbiol       Date:  2020-09-09       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.